Processing

Please wait...

Settings

Settings

1. WO2010019099 - 2-HYDROXY-ETHANESULFONATE SALT

Publication Number WO/2010/019099
Publication Date 18.02.2010
International Application No. PCT/SE2009/050926
International Filing Date 11.08.2009
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
439
the ring forming part of a bridged ring system, e.g. quinuclidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42
Oxazoles
A61K 31/439 (2006.01)
A61P 11/00 (2006.01)
A61K 31/42 (2006.01)
CPC
C07D 453/02
Applicants
  • ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje, SE (AllExceptUS)
  • PULMAGEN THERAPEUTICS (SYNERGY) LIMITED [GB/GB]; Fulmer hall Windmill Road Fulmer Slough Berkshire SL3 6HD, GB (AllExceptUS)
  • NADIN, Alan John [GB/GB]; GB (UsOnly)
Inventors
  • NADIN, Alan John; GB
Agents
  • ASTRAZENECA AB; AstraZeneca Intellectual Property S-151 85 Södertälje, SE
Priority Data
0814728.212.08.2008GB
0814729.012.08.2008GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) 2-HYDROXY-ETHANESULFONATE SALT
(FR) SEL 2-HYDROXY-ÉTHANESULFONATE
Abstract
(EN)
The invention provides (R) -1- [3- (R) -cyclohexyl-hydroxy-phenyl- methyl) -isoxazol-5-ylmethyl] -3- (3-f luoro-phenoxy) -1-azonia- bicyclo[2.2.2]octane 2-hydroxy ethanesulf onate, pharmaceutical compositions containing the compound and its use as a muscarinic antagonists, for the treatment of chronic obstructive pulmonary disease.
(FR)
L'invention concerne le 2-hydroxy-éthanesulfonate de (R)-1-[3-(R)-cyclohexyl-hydroxy-phényl-méthyl)-isoxazol-5-ylméthyl]-3- (3-fluoro-phénoxy)-1-azonia-bicyclo[2.2.2]octane, des compositions pharmaceutiques renfermant le composé et son utilisation en tant qu'antagoniste muscarinique, pour le traitement de la bronchopneumopathie chronique obstructive.
Latest bibliographic data on file with the International Bureau